TAF Switch Study in Hepatitis B Monoinfection
NCT02957994
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
82
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Tenofovir alafenamide fumarate
Sponsor
Asian Pacific Liver Center at Coalition of Inclusive Medicine